Lido Advisors LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 91.3% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 10,907 shares of the company’s stock after acquiring an additional 5,206 shares during the quarter. Lido Advisors LLC’s holdings in HCA Healthcare were worth $4,655,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in HCA Healthcare in the 2nd quarter worth approximately $5,069,974,000. Wellington Management Group LLP lifted its stake in HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the period. Darsana Capital Partners LP boosted its holdings in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares during the last quarter. Legal & General Group Plc acquired a new stake in shares of HCA Healthcare in the second quarter worth $410,992,000. Finally, Jupiter Topco LLC purchased a new position in shares of HCA Healthcare during the second quarter worth $371,138,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Stock Performance
Shares of NYSE HCA opened at $498.82 on Monday. The company has a market capitalization of $104.20 billion, a PE ratio of 16.53, a price-to-earnings-growth ratio of 1.67 and a beta of 1.11. The company’s fifty day moving average price is $452.79 and its 200 day moving average price is $445.91. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. The company had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.96 earnings per share. On average, equities analysts expect that HCA Healthcare, Inc. will post 30.14 EPS for the current year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 10.34%.
Recent HCA Healthcare Headlines
Investors following HCA have been watching these headlines:
- Neutral Sentiment: Zacks Research’s estimate changes were mixed: its FY2026 EPS forecast rose to $30.00, but it cut FY2027 to $30.87 and FY2028 to $33.98. The revisions offer a less uniformly strong forward earnings signal. HCA Healthcare analyst estimate updates
- Negative Sentiment: Medicaid policy is a risk to earnings: HCA expects $550 million to $650 million less in Medicaid supplemental payment benefits in 2027, potentially adding reimbursement pressure. Value stocks offer a different path forward
- Negative Sentiment: A senior vice president reportedly sold about $1.77 million in HCA shares. Insider sales can weigh on sentiment, although a sale alone does not establish a negative outlook. Insider selling at HCA Healthcare
Analysts Set New Price Targets
A number of research analysts recently issued reports on HCA shares. Royal Bank Of Canada boosted their target price on shares of HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a research report on Friday, October 30th. UBS Group cut their price target on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Barclays boosted their price objective on HCA Healthcare from $387.00 to $401.00 and gave the company an “equal weight” rating in a report on Thursday, October 29th. Truist Financial restated a “buy” rating and issued a $510.00 target price (up from $495.00) on shares of HCA Healthcare in a research note on Tuesday, November 3rd. Finally, Weiss Ratings raised HCA Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, November 10th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $480.13.
Read Our Latest Stock Analysis on HCA Healthcare
Insider Activity at HCA Healthcare
In other HCA Healthcare news, COO Jon M. Foster sold 21,713 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $494.95, for a total value of $10,746,849.35. Following the sale, the chief operating officer directly owned 10,000 shares of the company’s stock, valued at approximately $4,949,500. This trade represents a 68.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Erica Rossitto sold 3,500 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total value of $1,770,335.00. Following the transaction, the senior vice president directly owned 13,426 shares of the company’s stock, valued at approximately $6,791,005.06. The trade was a 20.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 36,413 shares of company stock worth $18,251,464 in the last 90 days. Corporate insiders own 1.50% of the company’s stock.
About HCA Healthcare
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
